T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Omnicom Group
OMC
$23.5B
| $126M | 0.03% |
1,612,888
+46,709
| +3% | +$3.57M |
|
552
Kinder Morgan
KMI
$70.7B
| $124M | 0.03% |
2,937,527
+100,860
| +4% | +$4.18M |
|
553
Encompass Health
EHC
$12.3B
| $124M | 0.03% |
3,500,211
+33,849
| +1% | +$1.16M |
|
|
WAGE
554
DELISTED
WageWorks, Inc.
WAGE
| $123M | 0.03% |
2,314,000
+32,700
| +1% | +$1.87M |
|
555
Papa John's
PZZA
$793M
| $122M | 0.03% |
1,981,740
-12,500
| -0.6% | -$779K |
|
556
Target
TGT
$69.9B
| $122M | 0.03% |
1,487,884
-354,822
| -19% | -$27.4M |
|
|
MHFI
557
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $122M | 0.03% |
1,177,809
-42,824
| -4% | -$4.21M |
|
558
Bankunited
BKU
$3.38B
| $122M | 0.03% |
3,718,530
+383,320
| +11% | +$11.8M |
|
|
XLRN
559
DELISTED
Acceleron Pharma
XLRN
| $121M | 0.03% |
3,174,335
-237,040
| -7% | -$9.43M |
|
|
FRAN
560
DELISTED
Francesca's Holdings Corporation
FRAN
| $120M | 0.02% |
563,655
+7,435
| +1% | +$1.41M |
|
561
Caterpillar
CAT
$393B
| $120M | 0.02% |
1,499,816
-629,123
| -30% | -$52.3M |
|
562
NorthWestern Energy
NWE
$4.34B
| $120M | 0.02% |
2,225,025
-93,310
| -4% | -$5.14M |
|
|
TMUSP
563
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $118M | 0.02% |
2,007,000
+7,000
| +0.4% | +$408K |
|
564
Marvell Technology
MRVL
$195B
| $118M | 0.02% |
8,039,838
+2,335,188
| +41% | +$36.9M |
|
565
Kroger
KR
$34.3B
| $118M | 0.02% |
3,065,730
-3,988,100
| -57% | -$142M |
|
566
Post Holdings
POST
$3.65B
| $117M | 0.02% |
3,808,341
+865,896
| +29% | +$26.5M |
|
567
Cameco
CCJ
$43.1B
| $117M | 0.02% |
8,372,570
+248,690
| +3% | +$3.72M |
|
568
TIM SA
TIMB
$8.69B
| $117M | 0.02% |
7,026,692
+3,728,470
| +113% | +$77.8M |
|
569
Enviri
NVRI
$583M
| $115M | 0.02% |
6,671,948
-2,180,920
| -25% | -$35.9M |
|
|
ICPT
570
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $114M | 0.02% |
405,087
+148,885
| +58% | +$32.2M |
|
|
JNS
571
DELISTED
Janus Capital Group Inc
JNS
| $114M | 0.02% |
6,643,465
-141,730
| -2% | -$2.42M |
|
|
PIR
572
DELISTED
Pier 1 Imports, Inc.
PIR
| $114M | 0.02% |
407,993
+57,069
| +16% | +$16.5M |
|
573
Red Robin
RRGB
$151M
| $114M | 0.02% |
1,310,213
-63,624
| -5% | -$5.16M |
|
574
Steris
STE
$23.1B
| $114M | 0.02% |
1,618,101
+10,030
| +0.6% | +$662K |
|
575
Westamerica Bancorp
WABC
$1.38B
| $113M | 0.02% |
2,623,618
-4,615
| -0.2% | -$201K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.